Bijker MS - Search Results

1

Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentation.

Bijker MS, van den Eeden SJ, Franken KL, Melief CJ, van der Burg SH, Offringa R. Bijker MS, et al. Eur J Immunol. 2008 Apr;38(4):1033-42. doi: 10.1002/eji.200737995. Eur J Immunol. 2008. PMID: 18350546 Free article.

2

Improved peptide vaccine strategies, creating synthetic artificial infections to maximize immune efficacy.

van der Burg SH, Bijker MS, Welters MJ, Offringa R, Melief CJ. van der Burg SH, et al. Among authors: bijker ms. Adv Drug Deliv Rev. 2006 Oct 1;58(8):916-30. doi: 10.1016/j.addr.2005.11.003. Epub 2006 Aug 12. Adv Drug Deliv Rev. 2006. PMID: 16979788 Review.

3

Multiple CD4 and CD8 T-cell activation parameters predict vaccine efficacy in vivo mediated by individual DC-activating agonists.

Welters MJ, Bijker MS, van den Eeden SJ, Franken KL, Melief CJ, Offringa R, van der Burg SH. Welters MJ, et al. Among authors: bijker ms. Vaccine. 2007 Feb 9;25(8):1379-89. doi: 10.1016/j.vaccine.2006.10.049. Epub 2006 Nov 7. Vaccine. 2007. PMID: 17123670

4

CD8+ CTL priming by exact peptide epitopes in incomplete Freund's adjuvant induces a vanishing CTL response, whereas long peptides induce sustained CTL reactivity.

Bijker MS, van den Eeden SJ, Franken KL, Melief CJ, Offringa R, van der Burg SH. Bijker MS, et al. J Immunol. 2007 Oct 15;179(8):5033-40. doi: 10.4049/jimmunol.179.8.5033. J Immunol. 2007. PMID: 17911588

5

Distinct uptake mechanisms but similar intracellular processing of two different toll-like receptor ligand-peptide conjugates in dendritic cells.

Khan S, Bijker MS, Weterings JJ, Tanke HJ, Adema GJ, van Hall T, Drijfhout JW, Melief CJ, Overkleeft HS, van der Marel GA, Filippov DV, van der Burg SH, Ossendorp F. Khan S, et al. Among authors: bijker ms. J Biol Chem. 2007 Jul 20;282(29):21145-59. doi: 10.1074/jbc.M701705200. Epub 2007 Apr 26. J Biol Chem. 2007. PMID: 17462991 Free article.

6

Design and development of synthetic peptide vaccines: past, present and future.

Bijker MS, Melief CJ, Offringa R, van der Burg SH. Bijker MS, et al. Expert Rev Vaccines. 2007 Aug;6(4):591-603. doi: 10.1586/14760584.6.4.591. Expert Rev Vaccines. 2007. PMID: 17669012 Review.

7

Spontaneous tumor rejection by cbl-b-deficient CD8+ T cells.

Loeser S, Loser K, Bijker MS, Rangachari M, van der Burg SH, Wada T, Beissert S, Melief CJ, Penninger JM. Loeser S, et al. Among authors: bijker ms. J Exp Med. 2007 Apr 16;204(4):879-91. doi: 10.1084/jem.20061699. Epub 2007 Apr 2. J Exp Med. 2007. PMID: 17403934 Free PMC article.

8

Dynamic programming of CD8+ T lymphocyte responses.

van Stipdonk MJ, Hardenberg G, Bijker MS, Lemmens EE, Droin NM, Green DR, Schoenberger SP. van Stipdonk MJ, et al. Among authors: bijker ms. Nat Immunol. 2003 Apr;4(4):361-5. doi: 10.1038/ni912. Epub 2003 Mar 17. Nat Immunol. 2003. PMID: 12640451

9

Peripheral-specific y2 receptor knockdown protects mice from high-fat diet-induced obesity.

Shi YC, Lin S, Castillo L, Aljanova A, Enriquez RF, Nguyen AD, Baldock PA, Zhang L, Bijker MS, Macia L, Yulyaningsih E, Zhang H, Lau J, Sainsbury A, Herzog H. Shi YC, et al. Among authors: bijker ms. Obesity (Silver Spring). 2011 Nov;19(11):2137-48. doi: 10.1038/oby.2011.99. Epub 2011 May 5. Obesity (Silver Spring). 2011. PMID: 21546930 Free article.

10

The neuropeptide Y system: pathophysiological and therapeutic implications in obesity and cancer.

Zhang L, Bijker MS, Herzog H. Zhang L, et al. Among authors: bijker ms. Pharmacol Ther. 2011 Jul;131(1):91-113. doi: 10.1016/j.pharmthera.2011.03.011. Epub 2011 Mar 23. Pharmacol Ther. 2011. PMID: 21439311 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page